Biofourmis Singapore Pte., Ltd. · Class II · Cleared May 9, 2024
| K-number | K233418 |
| Device name | Biofourmis Everion+ (G2) |
| Applicant | Biofourmis Singapore Pte., Ltd. |
| Product code | MSX |
| Device class | Class II |
| Decision date | May 9, 2024 |
| Decision | Substantially Equivalent |
| Regulation | 870.2300 |
AI extraction for this record is queued and will appear within 24 hours. View full FDA record →
View the full FDA submission: accessdata.fda.gov